12 Health Care Stocks Moving In Monday's Pre-Market Session
Atara Biotherapeutics Inc ATRA
$8.38
▲ +2.57%
(+$0.21)
🎈 Low Float
🗓️ Earnings Next Week
Open
$8.17
Prev Close
$8.17
Day Range
$7.86 – $8.67
52W Range
$3.92 – $19.15
Market Cap
$75.51M
P/E (TTM)
2.31
Beta
0.10
EPS (TTM)
$-0.86
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-10-16 |
| Shares Out. | 9,010,000 |
| Website | atarabio.com/ ↗ |
| Phone | 13026365400 |
| Employees | 13 |
| Revenue | $516,000 |
| Gross Profit | $392,000 |
| Net Income | -$4.1M |
| Total Assets | $20.0M |
| Total Liabilities | $57.3M |
| Equity | -$37.3M |
About Atara Biotherapeutics Inc
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Atara Biotherapeutics Inc is a publicly traded company under the ticker symbol ATRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)